Contineum Therapeutics (CTNM) Return on Equity (2023 - 2025)
Contineum Therapeutics (CTNM) has 3 years of Return on Equity data on record, last reported at 0.34% in Q3 2025.
- For Q3 2025, Return on Equity fell 17.0% year-over-year to 0.34%; the TTM value through Sep 2025 reached 0.34%, down 17.0%, while the annual FY2024 figure was 0.65%, N/A changed from the prior year.
- Return on Equity reached 0.34% in Q3 2025 per CTNM's latest filing, down from 0.32% in the prior quarter.
- Across five years, Return on Equity topped out at 0.17% in Q3 2024 and bottomed at 0.44% in Q2 2024.
- Average Return on Equity over 3 years is 0.29%, with a median of 0.29% recorded in 2024.
- Peak YoY movement for Return on Equity: grew 15bps in 2024, then fell -17bps in 2025.
- A 3-year view of Return on Equity shows it stood at 0.35% in 2023, then soared by 41bps to 0.21% in 2024, then crashed by -63bps to 0.34% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Equity were 0.34% in Q3 2025, 0.32% in Q2 2025, and 0.26% in Q1 2025.